Literature DB >> 8642270

An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils.

J T Schroeder1, L M Lichtenstein, S M MacDonald.   

Abstract

A novel recombinant histamine-releasing factor (rHFR), which stimulates secretion from a subpopulation of human basophils that express a particular type of immunoglobulin E (IgE) or IgE+, was found to induce interleukin-4 (IL-4) production from cells isolated from these same donors. The secretion of IL-4 protein induced by rHRF significantly correlated with histamine release and the amount of protein generated, and the kinetics were identical to those caused by anti-IgE activation. Furthermore, the ability of rHRF to induce IL-4 protein production from cells not normally responsive to this protein was transferred by passive sensitization with plasma containing IgE+ antibody. That this novel protein stimulates both mediator release and the secretion of IL-4 protein from human basophils suggests a prominent role for this molecule in allergic disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642270      PMCID: PMC2192336          DOI: 10.1084/jem.183.3.1265

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions.

Authors:  J A Warner; M M Pienkowski; M Plaut; P S Norman; L M Lichtenstein
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

2.  Basophil histamine release induced by a substance from stimulated human platelets.

Authors:  M A Orchard; A Kagey-Sobotka; D Proud; L M Lichtenstein
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

3.  Binding constants of IgE receptors on human blood basophils for IgE.

Authors:  J J Pruzansky; R Patterson
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

4.  Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma.

Authors:  T Koshino; S Teshima; N Fukushima; T Takaishi; K Hirai; Y Miyamoto; Y Arai; Y Sano; K Ito; Y Morita
Journal:  Clin Exp Allergy       Date:  1993-11       Impact factor: 5.018

5.  Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells.

Authors:  R Alam; P A Forsythe; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

Review 6.  Cells and secretagogues involved in the human late-phase response.

Authors:  E N Charlesworth; O Iliopoulos; S M MacDonald; A Kagey-Sobotka; L M Lichtenstein
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

7.  The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.

Authors:  R Bascom; U Pipkorn; L M Lichtenstein; R M Naclerio
Journal:  Am Rev Respir Dis       Date:  1988-08

8.  A histamine-releasing factor from activated human mononuclear cells.

Authors:  A P Kaplan; M Haak-Frendscho; A Fauci; C Dinarello; E Halbert
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Basophil counting with a new staining method using alcian blue.

Authors:  H S Gilbert; L Ornstein
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

10.  Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.

Authors:  S M MacDonald; L M Lichtenstein; D Proud; M Plaut; R M Naclerio; D W MacGlashan; A Kagey-Sobotka
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

View more
  14 in total

Review 1.  Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.

Authors:  Toshiaki Kawakami; Jiro Kitaura
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

2.  Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood.

Authors:  S Toyabe; U Kaneko; M Hara; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 3.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

4.  The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR.

Authors:  Ulrich-Axel Bommer; Anton V Borovjagin; Martin A Greagg; Ian W Jeffrey; Paul Russell; Kenneth G Laing; Melanie Lee; Michael J Clemens
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

5.  The effects of overexpression of histamine releasing factor (HRF) in a transgenic mouse model.

Authors:  Yueh-Chiao Yeh; Liping Xie; Jacqueline M Langdon; Allen C Myers; Sun-Young Oh; Zhou Zhu; Susan M Macdonald
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

6.  Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models.

Authors:  Jacqueline M Langdon; John T Schroeder; Becky M Vonakis; Anja P Bieneman; Kristin Chichester; Susan M Macdonald
Journal:  J Leukoc Biol       Date:  2008-07-14       Impact factor: 4.962

7.  Molecular cloning and characterization of the translationally controlled tumor protein from Fenneropenaeus chinensis.

Authors:  Shuai Wang; Xiao-Fan Zhao; Jin-Xing Wang
Journal:  Mol Biol Rep       Date:  2008-10-14       Impact factor: 2.316

8.  Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni.

Authors:  Kakuturu V N Rao; Lin Chen; Munirathinam Gnanasekar; Kalyanasundaram Ramaswamy
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

9.  Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.

Authors:  Becky M Vonakis; Donald W Macglashan; Natalia Vilariño; Jacqueline M Langdon; Rebecca S Scott; Susan M MacDonald
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

10.  Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy.

Authors:  Susan M Macdonald
Journal:  J Asthma Allergy       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.